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Summary: p120 Ras GTPase-activating protein (Ras-
GAP) encoded by the rasa1 gene in mice is a prototypi-
cal member of the RasGAP family of proteins involved in
negative-regulation of the p21 Ras proto-oncogene.
RasGAP has been implicated in signal transduction
through a number of cell surface receptors. In humans,
inactivating mutations in the coding region of the RASA1
gene cause capillary malformation arteriovenous mal-
formation. In mice, generalized disruption of the rasa1
gene results in early embryonic lethality associated with
defective vasculogenesis and increased apoptosis of
neuronal cells. The early lethality in this mouse model
precludes its use to further study the importance of Ras-
GAP as a regulator of cell function. Therefore, to circum-
vent this problem, we have generated a conditional
rasa1 knockout mouse. In this mouse, an exon that enc-
odes a part of the RasGAP protein essential for catalytic
activity has been flanked by loxP recognition sites. With
the use of different constitutive and inducible Cre trans-
genic mouse lines, we show that deletion of this exon
from the rasa1 locus results in effective loss of expres-
sion of catalytically-active RasGAP from a variety of
adult tissues. The conditional rasa1 mouse will be useful
for the analysis of the role of RasGAP in mature cell
types. genesis 45:762–767, 2007. VC 2007 Wiley-Liss, Inc.
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Ras is a small inner membrane-localized GTP-binding
protein that controls numerous cell processes including
growth, death, differentiation, migration, and polarity
(Matozaki et al., 2000; Olson and Marais, 2000). Activat-
ing mutations of Ras are observed commonly in human
cancer (Downward, 2003). Ras is active in its GTP-
bound state and inactive in its GDP bound state that
results from Ras hydrolysis of GTP. In its GTP-bound
form, Ras triggers the activation of Ras effector mole-
cules such as Raf-1 and phosphatidylinositol 3-kinase
(Rodriguez-Viciana et al., 1994; Vojtek et al., 1993). The
intrinsic GTPase activity of Ras is low and is considered
constant. Instead, other proteins are thought to control
the ratio of Ras-GTP to Ras-GDP during cellular signal
transduction. One such class of Ras-regulating proteins
are guanine nucleotide exchange factors (GEFs) (Bos
et al., 2007). Upon juxtaposition to Ras, GEFs eject GDP
from the Ras guanine nucleotide-binding pocket. Since
the concentration of GTP is higher than that of GDP in
the cytosol, the evacuated Ras preferentially binds GTP
resulting in Ras activation. Another class of Ras-regulat-
ing proteins are Ras GTPase-activating proteins (Ras-
GAPs) (Bos et al., 2007; Donovan et al., 2002). RasGAPs
increase the ability of Ras to hydrolyze bound GTP by
several orders of magnitude resulting in Ras inactivation.
A number of RasGAPs have now been described
including neurofibromin, RASA1-4, RASAL1 and L2, and
SynGAP (Bernards, 2003; Bos et al., 2007). Amongst
these, neurofibromin and p120 RasGAP (RasGAP) are
the prototypical members. Like other RasGAPs, RasGAP
contains several modular binding domains in addition to
its GAP domain. These include two Src homology-2
(SH2) domains, an SH3 domain, and pleckstrin homol-
ogy (PH) and protein kinase C2 homology domains (see
Fig. 1). These domains are thought to mediate recruit-
ment of RasGAP to receptors and membranes where-
upon it becomes localized to Ras. As a negative-regulator
of Ras, RasGAP has been implicated in signal transduc-
tion though numerous different receptors, e.g., the pla-
telet-derived growth factor (PDGF), epidermal growth
factor, ephrin, insulin, colony-stimulating factor-1 and T
cell antigen receptors (Downward et al., 1990; Holland
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et al., 1997; Kaplan et al., 1990; Margolis et al., 1990;
Pronk et al., 1992; Reedijk et al., 1990). In addition, Ras-
GAP has been shown to regulate cell death in response
to mild genotoxic stress through Ras-independent mech-
anisms (Yang and Widmann, 2001; Yang et al., 2004).
Recently, inactivating mutations of the human RASA1
gene have been shown to cause a novel clinical disorder
named capillary malformation-arteriovenous malforma-
tion (Boon et al., 2005; Eerola et al., 2003). Furthermore,
a targeted null mutation of rasa1 in mice causes early em-
bryonic lethality (d10.5) associated with vascular defects
and increased apoptotic cell death in developing brain
(Henkemeyer et al., 1995). These findings suggest an im-
portant physiological function for RasGAP at least in en-
dothelial cells and neuronal cells. Studies of fibroblasts
derived from rasa1 mutant embryos have additionally
revealed a role for RasGAP in directed movement and in
PDGF receptor signal transduction in this cell type (Kul-
karni et al., 2000; van der Geer et al., 1997). However,
because of early embryonic lethality of the rasa1 mutant
mice, it has not been possible to use these mice as a
model with which to further study the influence of inacti-
vation of RasGAP expression in adult tissues. To this end,
we generated a conditional allele of rasa1 in mice.
The rasa1 gene contains 25 exons, of which exon 18
encodes the entire arginine finger loop region of the
GAP domain essential for accelerated Ras hydrolysis of
GTP (see Fig. 1). Therefore, as a targeting strategy, we
attempted to flank exon 18 with loxP sites (see Fig. 2).
Following excision of exon 18 by Cre-mediated recombi-
nation, mutant rasa1 transcripts would, at the most, be
expected to direct the expression of catalytically-inactive
RasGAP molecules that lack a functional GAP domain.
Furthermore, nonsense sequences would be contained
in transcripts from this allele as exon 17 would remain
unspliced or spliced to downstream exons all of which
are out of frame with exon 17. Theoretically, therefore,
transcripts could be rapidly degraded by nonsense-medi-
ated RNA decay, resulting in complete loss of RasGAP
expression (Conti and Izaurralde, 2005).
A rasa1 targeting construct in which loxP sites were
inserted either side of exon 18 and a neomycin resistance
gene cassette (NeoR) flanked by FRT sites was inserted
downstream of the 30 loxP site in intron 18 was electropo-
rated into W4 embryonic stem (ES) cells (see Fig. 2). Fol-
lowing drug selection, correctly-targeted cloneswere iden-
tified by Southern blotting (see Fig. 3). Two such euploid
clones were used to generate chimeric mice, which were
bred with C57BL6/J mice to achieve germline transmission
of the targeted allele. Deletion of the NeoR cassette from
the targeted allele was then achieved by breeding of het-
erozygote targeted mice with C57BL6/J mice carrying a
Flp transgene under control of an actin promoter (Rodri-
guez et al., 2000). This allowed the generation of mice
with conditional rasa1 floxed (fl) alleles (see Fig. 3).
To demonstrate disruption of RasGAP expression, mice
harboring a rasa1 floxed allele were crossed with trans-
FIG. 1. Genomic organization of rasa1 and domain structure of
RasGAP. At top is depicted the intron/exon organization of rasa1
spanning 74 kbp on chromosome 13. The 25 exons are shown as
vertical bars. Below is a representation of the RasGAP protein
showing modular binding domains and the GAP domain. The GAP
domain is encoded by exons 16–25 of the rasa1 gene. Exon 18 of
rasa1 encodes the arginine finger loop region of the GAP domain
essential for catalytic activity.
FIG. 2. Generation of a conditional rasa1
allele. At top is shown the organization of
part of the endogenous rasa1 gene and tar-
geting construct used to generate a targeted
rasa1 allele in ES cells. The structure of the
targeted allele and a conditional rasa1 allele
that results from Flp-mediated excision of
the NeoR cassette is shown below. Loca-
tions of restriction sites, 50 and 30 DNA
probes and PCR primers used for Southern
blotting and genotyping are indicated.
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genic mice that express Cre in different immune cell line-
ages. Cre transgenic lines examined included Lck-Cre (T
cell lineage), Cd19-Cre (B cell lineage) and LysM-Cre (my-
eloid lineage) (Clausen et al., 1999; Hennet et al., 1995;
Rickert et al., 1997). Shown are the results of anti-RasGAP
Western blots of whole thymus and spleen cell suspen-
sions from Lck-Cre transgenic mice homozygous for wild-
type or rasa1 floxed alleles (Fig. 4a). In thymuses of
homozygote floxed mice, expression of full-length Ras-
GAP was almost extinguished. Of the trace amounts of
FIG. 3. Southern blotting and PCR genotyping of targeted and conditional rasa1 alleles. (a) Neomycin-resistant ES cell clones were
screened for correct targeting of rasa1 by Southern blotting of genomic DNA. Shown are Southern blots of one several correctly-targeted
clones using the indicated restriction enzymes and probes (see Fig. 2). (b) The ES clone shown in (a) was used to generate chimeric mice,
which were bred with wild-type C57BL/6 mice to achieve germline transmission of the targeted allele. Shown is a Southern blot of tail DNA
from four littermate pups from this cross. Pup 1 has inherited the targeted allele. (c) Mice with a targeted rasa1 allele were crossed with
actin-Flp transgenic mice to delete the NeoR cassette. Resulting heterozygote rasa1 floxed mice were intercrossed to generate wild-type,
heterozygote and homozygote rasa1 floxed progeny. Genotype was determined by PCR of tail DNA using forward and reverse primers
shown in Fig. 2. PCR products of 685 and 545 bp are generated from rasa1 floxed and wild-type alleles, respectively.
FIG. 4. RasGAP protein expression in rasal floxed Cre-transgenic mice. (a) RasGAP protein expression in thymus and spleen of Lck-Cre
transgenic wild type and homozygote rasa1 floxed mice was determined by Western blotting using a RasGAP antibody that reacts with
NH2-terminal SH2 and SH3 domains RasGAP. Blots were reprobed with an actin antibody to verify equal protein loading. Note the almost
complete loss of expression of RasGAP in thymus of the rasa1 floxed mice. Note also that no unique lower molecular mass RasGAP anti-
body-reactive bands are present in rasa1 floxed tracks. Identical results were obtained with an antibody that is specific for the RasGAP SH3
domain (not shown). (b) Homozygote rasa1 floxed mice with or without an inducible ubiquitin-Ert2-Cre transgene were injected with tamoxi-
fen intraperitoneally on two consecutive days. Seven days later mice were sacrificed and expression of RasGAP in different tissues was
determined by Western blotting as in (a). Equivalent protein loading was demonstrated by reprobing of blots with a GAPDH antibody.
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protein that remained, this could be accounted for by the
presence in thymus of nonT lineage cells such as macro-
phages, dendritic cells and epithelial cells that would not
be expected to express Cre (2–5% of total thymic cells).
Less RasGAP deletion was noted in whole spleen (Fig.
4a). However, this is consistent with the fact that T cells
comprise only 20–30% of total splenocytes. In lymph
node (LN), for example, where T cells comprise 60–70%
of total cells, levels of RasGAP expression are reduced
correspondingly, consistent with almost complete loss of
RasGAP expression in the T cell lineage (not shown). Sim-
ilar to results obtained with Lck-Cre, homozygous rasa1
floxed mice with Cd19-Cre or LysM-Cre transgenes
express much reduced levels of full-length RasGAP pro-
tein in splenic B cells and in bone-derived macrophages,
respectively (not shown). Experiments aimed at under-
standing the consequences of RasGAP loss in different
immune cell lineages are ongoing. Preliminary evidence
indicates that RasGAP is dispensable for the development
of immune cell lineages although performs an important
functional role in mature cells.
Mice with a rasa1 floxed allele were also crossed with
mice that carry an inducible Cre-ERT2 transgene under
the control of a ubiquitin promoter (Ruzankina et al.,
2007). The ubiquitously-expressed Cre-ERT2 protein
product encoded by this transgene is normally retained
within the cytoplasm. However, upon administration of
tamoxifen to mice, Cre-ERT2 is translocated to the nu-
cleus whereupon it has access to nuclear DNA and is able
to cut and splice loxP sites. Homozygous rasa1floxed
mice with or without the Cre-ERT2 transgene were thus
given single injections of tamoxifen on two consecutive
days. After 1 week, mice were then sacrificed and expres-
sion of RasGAP in different tissues was assessed by West-
ern blotting as before (Fig. 4b). As shown, substantial de-
letion of RasGAP was observed in each of thymus, spleen,
LN and kidney of rasa1 floxed Cre-ERT2 transgenic mice
following tamoxifen treatment. Slightly less deletion was
observed in lung and brain. However, in subsequent
experiments we determined that, when given two repeat
tamoxifen injections on consecutive days 1 week after the
initial injections, RasGAP expression was almost com-
pletely lost in these tissues (as determined in Western
blotting experiments performed 1 week later - not
shown). Therefore, these mice will be useful for study of
the influence of induced loss of RasGAP expression in a
variety of tissues of adult mice. Up to 3 months after ta-
moxifen treatment, mice remain healthy and show no
obvious morphological signs of disease. However, detailed
analyses of cell function have yet to be performed.
Importantly, in all tissues to which Cre has been tar-
geted, lower molecular mass forms of RasGAP have not
been identified in Western blots (Fig. 4a). Absence of
these forms cannot be explained by simple loss of anti-
body epitopes from truncated RasGAP protein(s) since
antibodies used in Western blot experiments were gen-
erated against NH2-terminal SH2 and SH3 domains.
Thus, deletion of exon 18 appears to result in a null
rasa1 allele with complete loss of RasGAP expression.
To examine if transcripts generated from the rasa1 exon
18-deleted allele were of low abundance relative to tran-
scripts generated from the wild-type rasa1 allele, we
performed RT-PCR analyses upon thymus RNA from het-
erozygote rasa1floxed mice with an Lck-Cre transgene
(see Fig. 5). Based upon analysis of protein expression in
homozygote rasa1floxed LCK-Cre transgenic mice (Fig.
4a), almost 100% deletion of the floxed allele is expected
in the heterozygotes. Using a forward primer located in
exon 17 and reverse primers located in exons 19, 21, or
23, it was demonstrated that transcripts generated from
the mutant allele are expressed much less abundantly
than transcripts generated from the wild-type allele in
the same tissue (see Fig. 5). Furthermore, these analyses
indicate that in mutant transcripts, exon 17 is spliced
exclusively to exon 19 and not to other downstream
exons. Results of RT-PCR reactions using a forward
primer based in exon 13 with the same reverse primers
concur with these conclusions (not shown). Low abun-
dance of mutant transcripts is probably explained by
nonsense-mediated RNA decay and is likely a major con-
tributing factor to our inability to detect truncated lower
molecular mass RasGAP forms in Western blots. Addi-
tionally, any lower molecular forms that are produced
may be subject to rapid proteolytic degradation.
METHODS
Generation of Conditional rasa1 Knockout Mice
A rasa1 targeting construct was assembled in p-loxP-
2FRT-PGKneo (Charles et al., 2006). 50 and 30 arms and
FIG. 5. Relative abundance of wild-type rasa1 and rasa1 exon 18-
deleted transcripts in thymus. Total RNA from thymus of Lck-Cre
transgenic heterozygote rasa1 floxed mice was analyzed by RT-
PCR using a forward primer based in exon 17 and reverse primers
based in exons 19, 21, or 23. PCR products generated from wild-
type and mutant rasa1 transcripts are indicated. For each primer
pair, the size of the smaller PCR product is consistent with an exon
17 to 19 splice of the mutant transcript. Note that in each case, the
abundance of mutant PCR product is low compared with that of the
wild-type PCR product.
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an inter-loxP region were generated by PCR from a
C57BL/6 genomic rasa1 BAC clone and were inserted
into the EcoRI/KpnI, KpnI/SalI and XhoI sites of p-loxP-
2FRT-PGKneo, respectively. Primers used for generation
of PCR products were: 50armF-50-GCG CGA ATT CGC
GGC CGC TTA GTC TTT CAG GCA TTT TAT AGC-30,
50armR-50-GCG CGG TAC CGA ATG CTT ATT TAC CAG
GAG TGA C-30; inter-loxPF-50-GCG CGG TAC CAG ATC
TAT AAC TTC GTA TAA TGT ATG CTA TAC GAA GTT
ATA AAT ATT TGA GCC TAT GAG GAC CA-30, inter-
loxPR-50-GCG CGT CGA CCA TAT CCA ACT TCA CAT
GAT GTG C-30; 30armF-50-GCG CCT CGA GGA ATT TCC
CAC ATG GAT AAT GCC A-30, 30armR-50-GCG CCT CGA
GAT ATG TTG TCA TGT AAG ATC AAT TTC A-30. The
resulting targeting construct contained a 50 loxP site
inserted in intron 17, a 30 loxP site and FRT-flanked NeoR
cassette inserted in intron 18 (900 bp downstream
from the 30 loxP site) and 3.5 kbp of upstream and
2.7 kbp of downstream flanking sequence (see Fig. 2).
Absence of PCR-induced errors was verified by DNA
sequencing. The construct was linearized with NotI
and electroporated into W4 ES cells of 129/Sv origin.
Neomycin-resistant clones were analyzed by Southern
blotting for correct targeting. 50 and 30 probes used in
Southern blotting experiments were generated by PCR
from the genomic rasa1 BAC clone using the following
primers: 50probeF-50-GCA AAA TTT CAT CTA GGA-30,
50probeR-50-CCT CAA TGA ACA AAC TTT-30; 30probeF-
50-GAA TGT CTA ATA GTG CCC-30, 30probeR-50-GAT
TAC TTA CAA TAA TTA-30. Of several identified euploid
correctly-targeted clones, two were injected into
C57BL/6J X (C57BL/6J X DBA/2) blastocysts to gener-
ate chimeric mice, which were then bred with C57BL/
6J mice to achieve germline transmission of the tar-
geted allele. As determined by Southern blotting of tail
DNA, germline transmission was achieved for both
clones. Mice that had inherited the targeted allele from
one of the ES cell clones (clone no.5041) were bred
with C57BL/6 actin-promoter-driven Flp transgenic
mice to delete the NeoR cassette (Rodriguez et al.,
2000). Mice were then intercrossed to generate wild-
type, heterozygote or homozygote rasa1 floxed mice
(see Fig. 3). Genotyping for rasa1 alleles was per-
formed by PCR of tail DNA using the following primers:
F-50-CAG TTT GTT CAT CAT GCT TTG-30, R-50-GAA GTT
TGA CTT TGG TTG CTG-30. Alternatively, rasa1 floxed
mice were crossed with C57BL/6 mice carrying a Cre
transgene driven by the proximal Lck promoter
(Taconic) or an inducible Cre-ERT2 transgene driven by
a ubiquitin promoter (Hennet et al., 1995; Ruzankina
et al., 2007). Heterozygote rasa1 floxed Cre-positive
progeny from these crosses were then backcrossed
with heterozygote rasa1 floxed mice to generate wild-
type or homozygote rasa1 floxed mice either not
expressing or expressing Cre transgenes (see Fig. 4). All
experiments performed upon mice were in compliance
with University of Michigan guidelines and were
approved by the University Committee on the Use and
Care of Animals.
Tamoxifen Administration
Two-month-old homozygous rasa1 floxed mice with
and without Cre-ERT2 transgenes were administered ta-
moxifen (MP biochemicals) to induce nuclear transloca-
tion of the Cre-ERT2 protein. On the basis of an earlier
study, in which the same Cre-ERT2 transgene was uti-
lized, a dose of 0.2 mg/g body weight of tamoxifen was
chosen (Ruzankina et al., 2007). Tamoxifen was injected
intraperitoneally in 200 ll of autoclaved corn oil
(Sigma). Mice were given two injections on consecutive
days. Seven days later mice were sacrificed for analysis.
Western Blotting
Lysates of different organs of 2-month-old Lck-Cre
transgenic wild-type and homozygous rasa1 floxed mice
and from tamoxifen-treated rasa1 floxed mice with and
without ubiquitin-Cre-ERT2 transgenes were prepared
by dounce homogenization in 1% NP-40 lysis buffer.
Expression of RasGAP in lysates was determined by
Western blotting using an antibody generated against the
SH2 and SH3 domains of RasGAP (Millipore). Blots were
stripped and reprobed with actin or GAPDH antibodies
to demonstrate equivalent protein loading.
RT-PCR
Total RNA was prepared from thymus of Lck-Cre trans-
genic heterozygote rasa1 floxed mice with Trizol rea-
gent (Gibco) and reverse-transcribed using a Superscript
II kit (Invitrogen) and random primers. cDNA was ampli-
fied by PCR using a forward primer based in exon 17
and reverse primers based in exons 19, 21, and 23.
Primer sequences are as follows: 17F-50-CAA AAG GAA
CTT CAT GTC GTC-30, 19R-50-GGA AGT ATT TCT GAA
GCC ATG-30, 21R-50-CTG AGA TGA TAT TAA ACA TCC-30,
23R-50-CCC AAG TTC ATC TAA AAA CAT-30.
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